BCL2 and posterior cortical atrophy: Thus far, numerous BCL-2 inhibitors have been discovered, such as ABT-101, ABT-199, ABT-263, ABT-737, etc. Clinical trials have reported the therapeutic effect of BCL-2 inhibitors in patients with PCa [189,190].